IFF's Leverage to Improve by 2025, Sales Momentum to Boost EBITDA, Projects Analyst
IFF's Leverage to Improve by 2025, Sales Momentum to Boost EBITDA, Projects Analyst
Stifel analyst Mark S. Astrachan upgraded International Flavors & Fragrances Inc. (NYSE:IFF) stock to Buy from Hold with an increased price target of $115 from $95.
Stifel分析師馬克·阿斯特拉坎將國際香精香料公司（紐約證券交易所代碼：IFF）的股票上調至持有買入，目標股價從95美元上調至115美元。
The analyst sees 2024 guidance as conservative and is increasing the sales and adjusted EBITDA forecasts for 2024-2025 by 1.5% and 4.4% above the company's top-end targets.
該分析師認爲2024年的指導是保守的，並將2024-2025年的銷售額和調整後的息稅折舊攤銷前利潤預測比公司的最高目標高出1.5％和4.4％。
IFF's volumes rebounded strongly in the first-quarter 2024, rising mid-single-digits after five quarters of decline, writes the analyst.
分析師寫道，IFF的交易量在2024年第一季度強勁反彈，在經歷了五個季度的下降之後，增長了中等個位數。
Also Read: IFF's Focus On Health And Environment Set To Drive Stock Momentum, Says Analyst
另請閱讀：分析師表示，IFF對健康和環境的關注將推動股票走勢
Astrachan expects mid-single-digit volume growth throughout 2024, driven by improved comparisons and a return to growth among many F&F customers in the second half of 2024.
Astrachan預計，在比較改善以及2024年下半年許多餐飲業客戶恢復增長的推動下，2024年全年銷量將實現中等個位數的增長。
The analyst further adds that incremental sales are projected to have a ~30% contribution margin, potentially adding about $95 million to the midpoint of the company's adjusted EBITDA guidance, equating to a ~4%-5% increase.
該分析師進一步補充說，增量銷售額預計將達到約30％的貢獻率，可能比公司調整後的息稅折舊攤銷前利潤預期的中點增加約9500萬美元，相當於增長約4％-5％。
Astrachan anticipates leverage will decrease to around 3.0x by year-end 2025, down from 4.7x at the end of the first quarter of 2024, primarily due to Pharma segment sales in the first half of 2025 and improving free cash flow.
Astrachan預計，到2025年底，槓桿率將從2024年第一季度末的4.7倍降至2025年底的3.0倍左右，這主要是由於2025年上半年製藥板塊的銷售以及自由現金流的改善。
The company expects to release the second quarter FY24 results on August 6, 2024.
該公司預計將於2024年8月6日發佈24財年第二季度業績。
IFF stock has gained over 15% in the last 12 months. Investors can gain exposure to the stock via SHL Telemedicine Ltd VanEck Morningstar Wide Moat Value ETF (BATS:MVAL) and IShares Emergent Food And AgTech Multisector ETF (NASDAQ:IVEG).
在過去的12個月中，IFF的股票上漲了15％以上。投資者可以通過SHL Telemedicine Ltd VanEck Morningstar Wide Morningstar Wide Value ETF（BATS: MVAL）和iShares Emergent Food And AgTech多板塊ETF（納斯達克股票代碼：IVEG）獲得股票敞口。
Price Action: IFF shares are up 2.78% at $98.33 at the last check Monday.
價格走勢：在週一的最後一次檢查中，IFF股價上漲2.78％，至98.33美元。
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
免責聲明：此內容部分是在人工智能工具的幫助下製作的，並由Benzinga的編輯審閱和發佈。